Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 10, Pages 3060
Publisher
MDPI AG
Online
2018-10-08
DOI
10.3390/ijms19103060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression
- (2018) Anzhou Xia et al. ONCOLOGY REPORTS
- Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL‑60 cells
- (2018) Cheng Wei et al. Oncology Letters
- Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer
- (2017) Min-Kyung Yeo et al. JOURNAL OF CLINICAL PATHOLOGY
- Cisplatin nephrotoxicity: a review of the literature
- (2017) Sandhya Manohar et al. JOURNAL OF NEPHROLOGY
- Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response
- (2017) Richard A. Burkhart et al. SURGICAL ONCOLOGY-OXFORD
- Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells
- (2017) Xiaoliang Chen et al. Oncotarget
- Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
- (2017) Xiaoling Qian et al. Oncotarget
- Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Human Cancer Cells through Reactive Oxygen Species-Mediated NF-κB Activations
- (2016) Ru Yuan et al. ACS Applied Materials & Interfaces
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma
- (2016) Partha Basu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- SF2312 is a natural phosphonate inhibitor of enolase
- (2016) Paul G Leonard et al. Nature Chemical Biology
- Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome
- (2016) Sergey V. Melnikov et al. NUCLEIC ACIDS RESEARCH
- Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance)
- (2016) Lisa Kottschade et al. SUPPORTIVE CARE IN CANCER
- Cloning, expression and cytotoxicity of granulin A, a novel polypeptide contained in human progranulin
- (2016) Xuan Wang et al. BioScience Trends
- Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway
- (2015) Qiao-Fen Fu et al. Journal of Hematology & Oncology
- Glutamate Receptors in the Central Nucleus of the Amygdala Mediate Cisplatin-Induced Malaise and Energy Balance Dysregulation through Direct Hindbrain Projections
- (2015) A. L. Alhadeff et al. JOURNAL OF NEUROSCIENCE
- Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
- (2015) Nick Thatcher et al. LANCET ONCOLOGY
- Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway
- (2015) WEI ZOU et al. ONCOLOGY REPORTS
- Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma
- (2014) K Nishimura et al. BRITISH JOURNAL OF CANCER
- Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen
- (2014) Raffit Hassan et al. CANCER
- Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews
- (2014) Julie L. Eiseman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- HIPEC ROC I: A phase i study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer
- (2014) Oliver Zivanovic et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic Induction of Apoptosis by Methylseleninic Acid and Cisplatin, The Role of ROS-ERK/AKT-p53 Pathway
- (2014) Yibo Zhang et al. MOLECULAR PHARMACEUTICS
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin-resistant bladder tumor cell line
- (2014) YOUNG JU LEE et al. ONCOLOGY REPORTS
- A Unique Small Molecule Inhibitor of Enolase Clarifies Its Role in Fundamental Biological Processes
- (2013) Da-Woon Jung et al. ACS Chemical Biology
- Long-Term Outcome and Morbidity After Treatment With Accelerated Radiotherapy and Weekly Cisplatin for Locally Advanced Head-and-Neck Cancer: Results of a Multidisciplinary Late Morbidity Clinic
- (2010) Heidi Rütten et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities
- (2008) Dmitri Tolkatchev et al. PROTEIN SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now